薬物に対する皮膚反応の割合. ボストン・コラボレーティブ・ドラッグ・サーベイランス・プログラムの報告です
まとめ
この研究では,一般的な薬によるアレルギー性皮膚反応を定量化するために,22,227人の入院患者を分析しました. 関連薬57種類を特定し,医師に薬剤による発疹,発疹,発疹を診断するためのデータを提供した.
科学分野:
- 薬理学 薬理学とは
- 皮膚科 皮膚科について
- クリニカル・メディシン 臨床医学
背景:
- 薬剤の副作用,特に皮膚症状は,医療における重要な懸念事項です.
- 薬物誘発性皮膚反応に関する正確なデータは,臨床的意思決定と患者の安全性にとって極めて重要です.
研究 の 目的:
- よく使われる医薬品に関連したアレルギー性皮膚反応の割合を推定する.
- 薬剤誘発の発疹,かゆみ,またはニキビを評価する医師に定量的,薬剤特異的なデータを提供するためです.
主な方法:
- 連続的にモニタリングされた22227人の入院患者のデータを分析した.
- 皮膚反応を引き起こすことに関与する薬物の特定と定量化.
主要な成果:
- 合計57の薬が皮膚反応と関連していることが判明しました.
- 22の薬物または薬物グループが,5つ以上の報告された反応と関連していました.
- 頻繁に処方される多くの薬は,このコホートでアレルギー性皮膚反応を引き起こすようには見えませんでした.
結論:
- この研究は,臨床医にとって,薬剤特有の貴重な定量データを提供します.
- この情報は,薬物誘発性皮膚疾患の微分診断に役立ちます.
- 医師は,これらの発見を使用して,潜在的なアレルギー薬剤反応を経験している患者をより良く管理することができます.
関連する概念動画
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:11Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...